Rasha Yehya Abdel-gaffar Mohamed
Lecturer
Evaluation of the Antimicrobial, Antioxidant, and Cytotoxicity Against MCF‑7 Breast Cell Lines of Biosynthesized Vanadium Nanoparticles
BioNanoScience • 2022
Publication Information
Authors
Rasha Y. Abdel‑Ghafar; Amira E. Sehim; Zeinab K. Hamza; Aziza A. El‑Nekeety ; Mosaad A. Abdel‑Wahhab
Keywords
Vanadium nanoparticles ; Green synthesis ; Antifungal ; Antibacterial ; Antioxidant ; Anticancer
Journal
BioNanoScience
Publisher
Springer US
Volume
12(4)
Issue
22 September
Pages
1097-1105.
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
This study was carried out to synthesize and characterize vanadium nanoparticles (VNPs) using orange peel extract and to
evaluate the antimicrobial, antioxidant, and anticancer activities of the biosynthesized VNPs. The antifungal activity was
tested against Fusarium graminearum, Alternaria alternata, Candida albicans, Aspergillus niger, and Aspergillus flavus.
However, the antibacterial activity was tested against Gram-positive bacteria (Staphylococcus aureus and Bacillus cereus)
and Gram-negative bacteria (Yersinia enterocolitica, Salmonella typhimurium, and Escherichia coli). The antioxidant activ-
ity was determined using the DPPH assay, and the anticancer activity was tested against the MCF-7 breast cell line. The
biosynthesized VNPs were mostly square with an average size of 80 ± 3 nm and zeta potential of − 50 ± 6 mV. VNPs showed
strong antifungal and antibacterial activities at a concentration of 100 μg/mL against the tested fungi and bacteria. These
biosynthesized VNPs showed strong antioxidant reaching 91.65% at a concentration of 2000 μg/mL. Moreover, the anticancer
activity against MCF-7 breast cell line with IC50 reached 15.99 μg. Therefore, it could be concluded that VNPs with strong
antimicrobial, antioxidant, and anticancer activities can be synthesized successfully using orange peel extract and can be
used in pharmaceutical and medical applications.
evaluate the antimicrobial, antioxidant, and anticancer activities of the biosynthesized VNPs. The antifungal activity was
tested against Fusarium graminearum, Alternaria alternata, Candida albicans, Aspergillus niger, and Aspergillus flavus.
However, the antibacterial activity was tested against Gram-positive bacteria (Staphylococcus aureus and Bacillus cereus)
and Gram-negative bacteria (Yersinia enterocolitica, Salmonella typhimurium, and Escherichia coli). The antioxidant activ-
ity was determined using the DPPH assay, and the anticancer activity was tested against the MCF-7 breast cell line. The
biosynthesized VNPs were mostly square with an average size of 80 ± 3 nm and zeta potential of − 50 ± 6 mV. VNPs showed
strong antifungal and antibacterial activities at a concentration of 100 μg/mL against the tested fungi and bacteria. These
biosynthesized VNPs showed strong antioxidant reaching 91.65% at a concentration of 2000 μg/mL. Moreover, the anticancer
activity against MCF-7 breast cell line with IC50 reached 15.99 μg. Therefore, it could be concluded that VNPs with strong
antimicrobial, antioxidant, and anticancer activities can be synthesized successfully using orange peel extract and can be
used in pharmaceutical and medical applications.